Hyperphosphorylation of type 2 ryanodine receptor in chronic heart failure
Chen, K.-y.; Huang, T.-g.
Zhonghua Xin Xue Guan Bing Za Zhi 35(7): 675-677
2007
ISSN/ISBN: 0253-3758 PMID: 17961442 Document Number: 606559
Document emailed within 1 workday
Related Documents
Aoyama, N. 2007: Effect of combination therapy with angiotensin Ii type i receptor and aldosterone receptor blockers in heart failure Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 5): 145-149Niizeki, T.; Takeishi, Y.; Arimoto, T.; Okuyama, H.; Takabatake, N.; Tachibana, H.; Nozaki, N.; Hirono, O.; Tsunoda, Y.; Miyashita, T.; Fukui, A.; Takahashi, H.; Koyama, Y.; Shishido, T.; Kubota, I. 2005: Serum heart-type fatty acid binding protein predicts cardiac events in elderly patients with chronic heart failure Journal of Cardiology 46(1): 9-15
Huang, J. 2006: The important role of angiotensin receptor blocker on treatment of chronic heart failure Zhonghua Xin Xue Guan Bing Za Zhi 34(9): 773-774
Kersting, F.; Samosny, G.; Kasper, W.; Schuster, H.P. 1981: Vasodilator therapy with alpha-receptor blockaders. Acute and chronic effect of prazosin and phentolamine in congestive heart failure Die Medizinische Welt 32(26): 1040-1045
Kuch, M.; Janiszewski, M.; Janiszewski, M.ł; Braksator, W.; Mamcarz, A.; Sadkowska, K.; Kuch, J.; Dłuzniewski, M.ła. 2006: Prognostic value of symptoms and signs of advanced heart failure and low left ventricle ejection fraction in patients after myocardial infarction with chronic heart failure Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 20(117): 285-288
Kikuchi, K.; Tanaka, H.; Gima, M.; Kashiwagi, Y.; Shida, H.; Kawamura, Y.; Hasebe, N. 2012: Abnormalities of magnesium (Mg) metabolism and therapeutic significance of Mg administration in patients with metabolic syndrome, type 2 diabetes, heart failure and chronic hemodialysis Clinical Calcium 22(8): 1217-1226
Tarantini, L.; Cioffi, G.; Opasich, C.; Di Lenarda, A.; Pulignano, G.; Del Sindaco, D.; De Feo, S.; Stefenelli, C.; Russo, P.; Catania, G. 2004: Pre-discharge initiation of beta-blocker therapy in elderly patients hospitalized for acute decompensation of chronic heart failure: an effective strategy for the implementation of beta-blockade in heart failure Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 5(6): 441-449
Wanic-Kossowska, M.; Piszczek, I.; Kurzawska-Firlej, D.; Halwa, S. 1992: Arterio-venous fistula of the Brescii type as a cause of circulatory failure in hemodialysed and dialysed patients with chronic renal failure Polski Tygodnik Lekarski 47(49-50): 1111-1112
Yamazawa, T.; Takeshima, H.; Sakurai, T.; Endo, M.; Iino, M. 1996: Subtype specificity of the ryanodine receptor for Ca2+ signal amplification in excitation-contraction coupling EMBO Journal 15(22): 6172-6177
Morita, K.; Kitayama, S.; Dohi, T. 2002: Physiological role of cyclic ADP-ribose as a novel endogenous agonist of ryanodine receptor in adrenal chromaffin cells Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 120(1): 96p-98p
Ichihara, Y.; Sasaki, J.; Kikuchi, H.; Ozawa, M.; Goto, Y.; Nonaka, I. 2000: Preliminary report: first identification of known mutation in the ryanodine receptor gene in a Japanese malignant hyperthermia pedigree Masui. Japanese Journal of Anesthesiology 49(4): 404-406
Sambuughin, N.; Sei, Y.; Gallagher, K.L.; Wyre, H.W.; Madsen, D.; Nelson, T.E.; Fletcher, J.E.; Rosenberg, H.; Muldoon, S.M. 2001: North American malignant hyperthermia population: screening of the ryanodine receptor gene and identification of novel mutations Anesthesiology 95(3): 594-599
Li, L.; Yi, S. 2015: Heart rate reduction is not the therapeutic target in the chronic heart failure therapy Zhonghua Xin Xue Guan Bing Za Zhi 43(3): 197-199
Fedorova, T.A.; Il'ina, I.V.; Sotnikova, T.I.; Rybakova, M.K. 2004: Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease Klinicheskaia Meditsina 82(11): 15-20
Fruhwald, F.M.; Kickenweiz, E.; Zweiker, R.; Klein, W. 2001: Angiotensin i receptor blockers for heart failure Wiener Medizinische Wochenschrift 151(7-8): 157-159
Bonarjee, V.V.; Dickstein, K. 2000: Use of angiotensin Ii receptor blockaders in heart failure Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 120(7): 817-821
Hoppe, U.C.; Erdmann, E. 1998: Guidelines for therapy of chronic heart failure. German Society of Cardiology-Heart and Cardiovascular Research Zeitschrift für Kardiologie 87(8): 645-658
Aleksandrova, E.B. 2013: Chronic heart failure in patients with arterial hypertension and ischemic heart desease: age and gender characteristics Kardiologiia 53(7): 40-44
Rumberger, E.; Ahrens, U. 1972: The effect of Ryanodine on the force-frequency-relationship of the heart muscle Pflugers Archiv: European Journal of Physiology 332: Suppl 332:r36
Kniazev, S.P.; Zhuchaev, K.V.; Hart, V.V.; Hardge, T. 1998: Discordance and cosegregation of swine halothane susceptibility and 1843 C-T mutation of their RYR1 locus responsible for the ryanodine receptor Genetika 34(12): 1648-1654